Corinna Warburton

IGF-I is required for normal embryonic growth in mice.

Lyn Powell-Braxton, Philip G. Hollingshead, Corinna Warburton et al. · Genes & Development · 1993 · 807 citations · Full text

Life Sciences, Developmental Biology, Endocrinology +7

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

Wieslawa H. Dragowska, Sherry A. Weppler, Jun Chih Wang et al. · PLoS ONE · 2013 · 101 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Treatment of HER-2/<b> <i>neu</i> </b> Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/<b> <i>neu</i> </b> and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction

Corinna Warburton, Wieslawa H. Dragowska, Karen A. Gelmon et al. · Clinical Cancer Research · 2004 · 81 citations

Medicine, Oncology, Pharmacology +17

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

Jessica Kalra, Corinna Warburton, Karen Fang et al. · Breast Cancer Research · 2009 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs

Gigi N.C. Chiu, Lincoln Edwards, Anita I. Kapanen et al. · Molecular Cancer Therapeutics · 2007 · 59 citations · Full text

Pharmacy, Immunology, Molecular Pharmaceutics +17